Avnet, Inc. (NASDAQ:AVT) Receives $93.25 Average Price Target from Analysts
Avnet, Inc. (NASDAQ:AVT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, two have assigned a buy rating and two […]
Brokerages Set AdaptHealth Corp. (NASDAQ:AHCO) Target Price at $10.29
Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating on the […]
e.l.f. Beauty (NYSE:ELF) Price Target Raised to $118.00
e.l.f. Beauty (NYSE:ELF – Get Free Report) had its price objective upped by equities researchers at Bank of America from $100.00 to $118.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective indicates a potential upside of 22.13% from the stock’s […]
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $5.00
Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) had its price target upped by investment analysts at Citigroup from $4.00 to $5.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 79.53% from the company’s […]
ODDITY Tech Ltd. (NASDAQ:ODD) Receives $27.23 Consensus PT from Analysts
Shares of ODDITY Tech Ltd. (NASDAQ:ODD – Get Free Report) have been given an average rating of “Reduce” by the fourteen research firms that are currently covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell recommendation and ten have assigned a hold recommendation to the company. The average 1-year target […]
Wedbush Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $17.00
Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price objective hoisted by analysts at Wedbush from $16.00 to $17.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Wedbush’s price objective suggests a potential upside of 41.42% from the company’s […]
FIGS, Inc. (NYSE:FIGS) Receives $18.71 Consensus Price Target from Brokerages
Shares of FIGS, Inc. (NYSE:FIGS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven analysts that are covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective […]
PENN Entertainment, Inc. (NASDAQ:PENN) Receives $23.53 Average Target Price from Brokerages
PENN Entertainment, Inc. (NASDAQ:PENN – Get Free Report) has received an average rating of “Moderate Buy” from the twenty research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and twelve have assigned a buy rating to the […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives $105.57 Consensus Price Target from Analysts
Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
Integer Holdings Corporation (NYSE:ITGR) Receives $109.86 Average Price Target from Analysts
Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the fourteen analysts that are covering the stock, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts […]
Brixmor Property Group Inc. (NYSE:BRX) Receives $34.55 Average PT from Analysts
Shares of Brixmor Property Group Inc. (NYSE:BRX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have assigned […]
Avita Medical Inc. (NASDAQ:RCEL) Receives $11.40 Consensus Price Target from Brokerages
Shares of Avita Medical Inc. (NASDAQ:RCEL – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have issued a buy recommendation […]
National Energy Services Reunited (NASDAQ:NESR) Receives $33.57 Consensus Price Target from Analysts
Shares of National Energy Services Reunited (NASDAQ:NESR – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […]
Apogee Therapeutics Inc. (NASDAQ:APGE) Given Consensus Rating of “Hold” by Analysts
Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) has been assigned a consensus recommendation of “Hold” from the nineteen ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, fifteen have assigned a hold recommendation, two have assigned a buy recommendation and one has […]
AstraZeneca PLC (LON:AZN) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year […]
last updated on 16 Sep 10:27